Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Topics in Current Chemistry|April 26, 2011
Enantioselective sensing by luminescenceAlessandro Accetta, Roberto Corradini, Rosangela Marchelli
Chirality|September 29, 2015
Structural Studies on Porphyrin-PNA Conjugates in Parallel PNA:PNA Duplexes: Effect of Stacking Interactions on HelicityAlessandro Accetta, Ana G Petrovic, Rosangela Marchelli, et al.
Artificial DNA, PNA & XNA|July 10, 2012
PNA bearing 5-azidomethyluracil: a novel approach for solid and solution phase modificationAlex Manicardi, Alessandro Accetta, Tullia Tedeschi, et al.
Journal of Medicinal Chemistry|December 17, 2008
New uracil dimers showing erythroid differentiation inducing activitiesAlessandro Accetta, Roberto Corradini, Stefano Sforza, et al.
Organic & Biomolecular Chemistry|July 4, 2013
PNA-NLS conjugates as single-molecular activators of target sites in double-stranded DNA for site-selective scissionYuichiro Aiba, Yuya Hamano, Wataru Kameshima, et al.
RSC Medicinal Chemistry|September 19, 2024
Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitorsDaniele Pala, David Clark, Christine Edwards, et al.
European Journal of Pharmacology|October 1, 2011
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cellsEleonora Brognara, Ilaria Lampronti, Giulia Breveglieri, et al.
European Journal of Pharmacology|February 13, 2019
Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertensionSilvia Cantoni, Stefano Cavalli, Fiorella Pastore, et al.
Frontiers in Pharmacology|February 8, 2021
Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and RepairXinhui Wu, Vicky Verschut, Manon E Woest, et al.
Journal of Medicinal Chemistry|July 28, 2022
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory DiseasesLaura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Pageof 2